Quad-Cities Investment Group’s Dr. Reddy's Laboratories RDY Stock Holding History

Quad-Cities Investment Group’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-5,000	Closed	-$38K	–	584
2019 Q3	$38K	Hold	5,000	–	–	0.03%	377
2019 Q2	$37K	Hold	5,000	–	–	0.03%	386
2019 Q1	$41K	Hold	5,000	–	–	0.04%	365
2018 Q4	$38K	Sell	5,000 -1,000	-17%	-$7.03K	0.04%	370
2018 Q3	$42K	Sell	6,000 -1,000	-14%	-$6.68K	0.04%	380
2018 Q2	$44K	Buy	+7,000	New	+$44.2K	0.04%	366

Other funds holding RDY

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Aperio Group Sausalito, California $33.8B AUM 31.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Quad-Cities Investment Group's RDY Position: Q4 2019 in Review

Quad-Cities Investment Group sold out of Dr. Reddy's Laboratories (RDY) in Q4 2019, closing a stake of 5,000 shares — an estimated $38K sold.

Quad-Cities Investment Group first reported a position in RDY in Q2 2018 and held it in 6 quarters. The position peaked at $44K in Q2 2018. 148 funds tracked by Wall St. Rank hold RDY as of Q4 2019.

Quad-Cities Investment Group reported no remaining Dr. Reddy's Laboratories position as of Q4 2019 after selling out during the quarter.
Quad-Cities Investment Group sold 5,000 Dr. Reddy's Laboratories shares in Q4 2019, an estimated $38K.
Quad-Cities Investment Group first reported a position in Dr. Reddy's Laboratories in Q2 2018 and held it in 6 quarters.
Quad-Cities Investment Group's Dr. Reddy's Laboratories position peaked at $44K in Q2 2018.
148 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2019.

Based on Quad-Cities Investment Group's 13F filing for Q4 2019, filed 28 Jan 2020.